Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert F Garry

Showing results (151-160 of 204) with videos related to

Pageof 21
Sort By:
Science Translational Medicine|October 26, 2022
A cocktail of protective antibodies subverts the dense glycan shield of Lassa virusHaoyang Li, Tierra Buck, Michelle Zandonatti, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2018
Analysis of CD8<sup>+</sup> T cell response during the 2013-2016 Ebola epidemic in West AfricaSaori Sakabe, Brian M Sullivan, Jessica N Hartnett, et al.
Microorganisms|April 3, 2021
Space-Time Trends in Lassa Fever in Sierra Leone by ELISA Serostatus, 2012-2019Jeffrey G Shaffer, John S Schieffelin, Mambu Momoh, et al.
Cell|September 4, 2021
The origins of SARS-CoV-2: A critical reviewEdward C Holmes, Stephen A Goldstein, Angela L Rasmussen, et al.
Cell|September 20, 2024
Genetic tracing of market wildlife and viruses at the epicenter of the COVID-19 pandemicAlexander Crits-Christoph, Joshua I Levy, Jonathan E Pekar, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Novel Tools for Lassa Virus Surveillance in Peri-domestic RodentsAllison R Smither, James Koninga, Franklyn B Kanneh, et al.
The Journal of Infectious Diseases|May 27, 2024
Ebola Virus-Specific Neutralizing Antibody Persists at High Levels in Survivors 2 Years After Resolution of Disease in a Sierra Leonean CohortNell G Bond, Kayla R Shore, Emily J Engel, et al.
The Journal of Infectious Diseases|May 22, 2020
Ebola-Specific CD8+ and CD4+ T-Cell Responses in Sierra Leonean Ebola Virus Survivors With or Without Post-Ebola SequelaeStephanie M LaVergne, Saori Sakabe, Lansana Kanneh, et al.
Frontiers in Public Health|April 11, 2025
Use of a pathogen X tabletop exercise to assess the operational response preparedness of an emerging infectious diseases research networkRachael Lee, Jennifer Hemingway-Foday, Nefer Batsuli, et al.
Immunity|April 14, 2021
A Fc engineering approach to define functional humoral correlates of immunity against Ebola virusBronwyn M Gunn, Richard Lu, Matthew D Slein, et al.
Pageof 21

Showing results (151-160 of 204) with videos related to

Sort By:
Pageof 21
Science Translational Medicine|October 26, 2022
A cocktail of protective antibodies subverts the dense glycan shield of Lassa virusHaoyang Li, Tierra Buck, Michelle Zandonatti, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2018
Analysis of CD8<sup>+</sup> T cell response during the 2013-2016 Ebola epidemic in West AfricaSaori Sakabe, Brian M Sullivan, Jessica N Hartnett, et al.
Microorganisms|April 3, 2021
Space-Time Trends in Lassa Fever in Sierra Leone by ELISA Serostatus, 2012-2019Jeffrey G Shaffer, John S Schieffelin, Mambu Momoh, et al.
Cell|September 4, 2021
The origins of SARS-CoV-2: A critical reviewEdward C Holmes, Stephen A Goldstein, Angela L Rasmussen, et al.
Cell|September 20, 2024
Genetic tracing of market wildlife and viruses at the epicenter of the COVID-19 pandemicAlexander Crits-Christoph, Joshua I Levy, Jonathan E Pekar, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Novel Tools for Lassa Virus Surveillance in Peri-domestic RodentsAllison R Smither, James Koninga, Franklyn B Kanneh, et al.
The Journal of Infectious Diseases|May 27, 2024
Ebola Virus-Specific Neutralizing Antibody Persists at High Levels in Survivors 2 Years After Resolution of Disease in a Sierra Leonean CohortNell G Bond, Kayla R Shore, Emily J Engel, et al.
The Journal of Infectious Diseases|May 22, 2020
Ebola-Specific CD8+ and CD4+ T-Cell Responses in Sierra Leonean Ebola Virus Survivors With or Without Post-Ebola SequelaeStephanie M LaVergne, Saori Sakabe, Lansana Kanneh, et al.
Frontiers in Public Health|April 11, 2025
Use of a pathogen X tabletop exercise to assess the operational response preparedness of an emerging infectious diseases research networkRachael Lee, Jennifer Hemingway-Foday, Nefer Batsuli, et al.
Immunity|April 14, 2021
A Fc engineering approach to define functional humoral correlates of immunity against Ebola virusBronwyn M Gunn, Richard Lu, Matthew D Slein, et al.
Pageof 21